CK 2289

Known as: CK-2289 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
CK-2289 is an inhibitor of type III cyclic 3'5'-adenosine monophosphate phosphodiesterase with potential utility in the treatment… (More)
Is this relevant?
1991
1991
We examined the interaction between ouabain and CK-2289, a new bivalent inodilator, and compared their effect with that of… (More)
Is this relevant?
1991
1991
We examined the hemodynamic profile of CK-2289, a new imidazolone developed for the treatment of congestive heart failure, in the… (More)
Is this relevant?